Edition:
United Kingdom

People: Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

6.07CAD
24 May 2019
Change (% chg)

$0.11 (+1.85%)
Prev Close
$5.96
Open
$5.98
Day's High
$6.13
Day's Low
$5.85
Volume
200,554
Avg. Vol
168,634
52-wk High
$14.75
52-wk Low
$5.17

Frame, Sheila 

Ms. Sheila M. Frame is Independent Director of the company. Ms. Frame is currently Vice President and Head Biopharmaceuticals, North America at Sandoz Inc. (a division of Novartis) in the United States. Previously, she successively held the positions of Worldwide General Manager, Immunoscience, Worldwide Commercial Lead, Opdivo ® new indications and Biomarker diagnostics, Worldwide Commercial Lead Yervoy ® from the US and Vice President, specialty business at Bristol-Myers Squibb in Canada. She was also called upon to occupy several senior roles at UCB Inc. and at AstraZeneca in Canada, the US and the Nordics. Ms. Frame completed the requirements for the Chartered Corporate Director program with the Director's college in 2006. She also completed a Masters of Business Administration at Concordia University in Montreal and she holds a Bachelor of Arts from York University in Toronto.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --